Patents by Inventor Ole Buchardt, deceased

Ole Buchardt, deceased has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6107470
    Abstract: Peptide nucleic acids containing histidine moieties are provided. These compounds have applications including diagnostics, research and potential therapeutics.
    Type: Grant
    Filed: January 4, 1999
    Date of Patent: August 22, 2000
    Inventors: Peter E. Nielsen, Ole Buchardt, deceased, Rolf H. Berg, Michael Egholm
  • Patent number: 5977296
    Abstract: A novel class of peptide nucleic acid monomers are synthesized having chirality in the backbone. Peptide nucleic acid oligomers are synthesized to incorporate these chiral monomers.
    Type: Grant
    Filed: December 28, 1994
    Date of Patent: November 2, 1999
    Inventors: Peter Nielsen, Ole Buchardt, deceased, by Mrs. D. Buchardt, Pierre Lagriffoul
  • Patent number: 5972610
    Abstract: The present invention relates to the use of nucleic acid analogues in blocking nucleic acid amplification procedures and to diagnostic and analytical techniques based thereon. Also included are kits for use in the conduct of nucleic acid amplification reactions.
    Type: Grant
    Filed: October 8, 1997
    Date of Patent: October 26, 1999
    Inventors: Ole Buchardt, deceased, by Dorte Buchardt, legal representative, Michael Egholm, Peter Eigil Nielsen, Rolf Henrik Berg, Christopher John Stanley
  • Patent number: 5891625
    Abstract: Nucleic acid analogues such as peptide-nucleic acids (PNAs) which hybridize strongly to nucleic acids are used to inhibit nucleic acid amplification procedures such as PCR. False positives in subsequent PCR assays are prevented by hybridizing a PNA to PCR amplification products. Assays capable of discriminating between single base mutants are conducted by using a PNA hybridizing to one of the two allelic forms to inhibit a PCR amplification of that form selectively. Asymmetric PCR amplifications are carried out by starting a PCR symmetrically using like quantities of forward and reverse primers, and, once the amplification is established, disabling one primer by hybridizing a PNA thereto.
    Type: Grant
    Filed: March 10, 1995
    Date of Patent: April 6, 1999
    Inventors: Ole Buchardt, deceased, Michael Egholm, Peter Eigil Nielsen, Rolf Henrik Berg, Christopher John Stanley
  • Patent number: 5837459
    Abstract: RNA is transcribed from a double stranded DNA template by forming a complex by hybridizing to the template at a desired transcription initiation site one or more oligonucleic acid analogues of the PNA type capable of forming a transcription initiation site with the DNA and exposing the complex to the action of a DNA dependant RNA polymerase in the presence of nucleoside triphosphates. Equal length transcripts may be obtained by placing a block to transcription downstream from the initiation site or by cutting the template at such a selected location. The initiation site is formed by displacement of one strand of the DNA locally by the PNA hybridization.
    Type: Grant
    Filed: May 24, 1996
    Date of Patent: November 17, 1998
    Assignee: Boehringer Mannheim GmbH
    Inventors: Rolf Henrik Berg, Ole Buchardt, deceased, Michael Egholm, Peter Eigil Nielsen
  • Patent number: 5786461
    Abstract: A novel class of compounds, known as peptide nucleic acids, bind complementary DNA and RNA strands more strongly than the corresponding DNA or RNA strands, and exhibit increased sequence specificity and solubility. The peptide nucleic acids comprise ligands selected from a group consisting of naturally-occurring nucleobases and non-naturally-occurring nucleobases attached to a polyamide backbone, and contain alkylamine side chains.
    Type: Grant
    Filed: May 1, 1997
    Date of Patent: July 28, 1998
    Inventors: Ole Buchardt, deceased, Michael Egholm, Peter Eigil Nielsen, Rolf Henrik Berg, Dorte Buchardt
  • Patent number: 5766855
    Abstract: A novel class of compounds, known as peptide nucleic acids, bind complementary DNA and RNA strands more strongly than a corresponding DNA strand, and exhibit increased sequence specificity and binding affinity. Methods of increasing binding affinity and sequence specificity of peptide nucleic acids are provided wherein some peptide nucleic acids comprise ligands selected from a group consisting of naturally-occurring nucleobases and non-naturally-occurring nucleobases attached to a polyamide backbone, while other peptide nucleic acids contain at least one 2,6-diaminopurine nucleobase and at least one C.sub.1 -C.sub.8 alkylamine side chain.
    Type: Grant
    Filed: July 24, 1996
    Date of Patent: June 16, 1998
    Inventors: Ole Buchardt, deceased, Michael Egholm, Peter Eigil Nielsen, Rolf Henrik Berg, by Dorte Buchardt, executor
  • Patent number: 5736336
    Abstract: A novel class of compounds, known as peptide nucleic acids, bind complementary DNA and RNA strands more strongly than a corresponding DNA strand, and exhibit increased sequence specificity and solubility. The peptide nucleic acids comprise ligands selected from a group consisting of naturally-occurring nucleobases and non-naturally-occurring nucleobases attached to a polyamide backbone, and contain C.sub.1 -C.sub.8 alkylamine side chains. Methods of enhancing the solubility, binding affinity and sequence specificity of PNAs are provided.
    Type: Grant
    Filed: May 1, 1997
    Date of Patent: April 7, 1998
    Inventors: Ole Buchardt, deceased, by Dorte Buchardt, representative, Michael Egholm, Peter Eigil Nielsen, Rolf Henrik Berg
  • Patent number: 5719262
    Abstract: A novel class of compounds, known as peptide nucleic acids, bind complementary DNA and RNA strands more strongly than the corresponding DNA or RNA strands, and exhibit increased sequence specificity and solubility. The peptide nucleic acids comprise ligands selected from a group consisting of naturally-occurring nucleobases and non-naturally-occurring nucleobases attached to a polyamide backbone, and contain alkylamine side chains.
    Type: Grant
    Filed: July 24, 1996
    Date of Patent: February 17, 1998
    Inventors: Ole Buchardt, deceased, by Dorte Buchardt, legal representative, Michael Egholm, Peter Eigil Nielsen, Rolf Henrik Berg
  • Patent number: 5714331
    Abstract: A novel class of compounds, known as peptide nucleic acids, bind complementary DNA and RNA strands more strongly than a corresponding DNA strand, and exhibit increased sequence specificity and solubility. The peptide nucleic acids comprise ligands selected from a group consisting of naturally-occurring nucleobases and non-naturally-occurring nucleobases attached to a polyamide backbone, and contain C.sub.1 -C.sub.8 alkylamine side chains. Methods of enhancing the solubility, binding affinity and sequence specificity of PNAs are provided.
    Type: Grant
    Filed: July 24, 1996
    Date of Patent: February 3, 1998
    Inventors: Ole Buchardt, deceased, by Dorte Buchardt, representative, Michael Egholm, Peter Eigil Nielsen, Rolf Henrik Berg